190 related articles for article (PubMed ID: 31124578)
41. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
Hyde RK; Liu P; Friedman AD
Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
[TBL] [Abstract][Full Text] [Related]
42. Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder.
Churpek JE; Garcia JS; Madzo J; Jackson SA; Onel K; Godley LA
Leuk Lymphoma; 2010 Oct; 51(10):1931-5. PubMed ID: 20846103
[No Abstract] [Full Text] [Related]
43. Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree.
Tawana K; Wang J; Király PA; Kállay K; Benyó G; Zombori M; Csomor J; Al Seraihi A; Rio-Machin A; Matolcsy A; Chelala C; Cavenagh J; Fitzgibbon J; Bödör C
Eur J Hum Genet; 2017 Aug; 25(8):1020-1024. PubMed ID: 28513614
[TBL] [Abstract][Full Text] [Related]
44. [Familial leukemia due to germline RUNX1 mutations: lessons learned from two decades of research and unsolved problems].
Osato M; Nambu A
Rinsho Ketsueki; 2020; 61(6):687-696. PubMed ID: 32624544
[TBL] [Abstract][Full Text] [Related]
45. Whole-exome sequencing confirmation of a novel heterozygous mutation in RUNX1 in a pregnant woman with platelet disorder.
Obata M; Tsutsumi S; Makino S; Takahashi K; Watanabe N; Yoshida T; Tamiya G; Kurachi H
Platelets; 2015; 26(4):364-9. PubMed ID: 24853048
[TBL] [Abstract][Full Text] [Related]
46. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.
Metzeler KH; Bloomfield CD
Adv Exp Med Biol; 2017; 962():175-199. PubMed ID: 28299658
[TBL] [Abstract][Full Text] [Related]
47. Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS.
Harada H; Harada Y; Kimura A
Curr Cancer Drug Targets; 2006 Sep; 6(6):553-65. PubMed ID: 17017876
[TBL] [Abstract][Full Text] [Related]
48. Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies?
Vobugari N; Heuston C; Lai C
Clin Adv Hematol Oncol; 2022 Jun; 20(6):375-383. PubMed ID: 35731608
[TBL] [Abstract][Full Text] [Related]
49. Recurrent CDC25C mutations drive malignant transformation in FPD/AML.
Yoshimi A; Toya T; Kawazu M; Ueno T; Tsukamoto A; Iizuka H; Nakagawa M; Nannya Y; Arai S; Harada H; Usuki K; Hayashi Y; Ito E; Kirito K; Nakajima H; Ichikawa M; Mano H; Kurokawa M
Nat Commun; 2014 Aug; 5():4770. PubMed ID: 25159113
[TBL] [Abstract][Full Text] [Related]
50. Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia.
Foster N; Paulsson K; Sales M; Cunningham J; Groves M; O'Connor N; Begum S; Stubbs T; McMullan DJ; Griffiths M; Pratt N; Tauro S
Br J Haematol; 2010 Mar; 148(6):938-43. PubMed ID: 20064152
[TBL] [Abstract][Full Text] [Related]
51. A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.
Buijs A; Poddighe P; van Wijk R; van Solinge W; Borst E; Verdonck L; Hagenbeek A; Pearson P; Lokhorst H
Blood; 2001 Nov; 98(9):2856-8. PubMed ID: 11675361
[TBL] [Abstract][Full Text] [Related]
52. [Analysis of RUNX1 Gene Mutation in Patients with Myelodysplastic Syndrome].
Cai XH; Chen MY; Chao HY; Jiang NK; Lu XZ; Han WM; Qin W; Jia ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):202-208. PubMed ID: 32027277
[TBL] [Abstract][Full Text] [Related]
53. Validation and clinical application of transactivation assays for RUNX1 variant classification.
Decker M; Agarwal A; Benneche A; Churpek J; Duployez N; Duvall A; Ernst MPT; Förster A; Høberg-Vetti H; Hofmann I; Nash M; Raaijmakers MHGP; Tvedt THA; Vlachos A; Schlegelberger B; Illig T; Ripperger T
Blood Adv; 2022 Jun; 6(11):3195-3200. PubMed ID: 35026845
[TBL] [Abstract][Full Text] [Related]
54. Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia.
Haslam K; Langabeer SE; Hayat A; Conneally E; Vandenberghe E
Br J Haematol; 2016 Oct; 175(1):161-3. PubMed ID: 26525156
[No Abstract] [Full Text] [Related]
55. Genetic basis of myeloid transformation in familial platelet disorder/acute myeloid leukemia patients with haploinsufficient RUNX1 allele.
Sakurai M; Kasahara H; Yoshida K; Yoshimi A; Kunimoto H; Watanabe N; Shiraishi Y; Chiba K; Tanaka H; Harada Y; Harada H; Kawakita T; Kurokawa M; Miyano S; Takahashi S; Ogawa S; Okamoto S; Nakajima H
Blood Cancer J; 2016 Feb; 6(2):e392. PubMed ID: 26849013
[No Abstract] [Full Text] [Related]
56. RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.
Okada Y; Watanabe M; Nakai T; Kamikawa Y; Shimizu M; Fukuhara Y; Yonekura M; Matsuura E; Hoshika Y; Nagai R; Aird WC; Doi T
J Thromb Haemost; 2013 Sep; 11(9):1742-50. PubMed ID: 23848403
[TBL] [Abstract][Full Text] [Related]
57. T cell acute lymphoblastic leukemia arising from familial platelet disorder.
Nishimoto N; Imai Y; Ueda K; Nakagawa M; Shinohara A; Ichikawa M; Nannya Y; Kurokawa M
Int J Hematol; 2010 Jul; 92(1):194-7. PubMed ID: 20549580
[TBL] [Abstract][Full Text] [Related]
58. Beyond Pathogenic
Förster A; Decker M; Schlegelberger B; Ripperger T
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884491
[TBL] [Abstract][Full Text] [Related]
59. Natural history study of patients with familial platelet disorder with associated myeloid malignancy.
Cunningham L; Merguerian M; Calvo KR; Davis J; Deuitch NT; Dulau-Florea A; Patel N; Yu K; Sacco K; Bhattacharya S; Passi M; Ozkaya N; De Leon S; Chong S; Craft K; Diemer J; Bresciani E; O'Brien K; Andrews EJ; Park N; Hathaway L; Cowen EW; Heller T; Ryan K; Barochia A; Nghiem K; Niemela J; Rosenzweig S; Young DJ; Frischmeyer-Guerrerio PA; Braylan R; Liu PP
Blood; 2023 Dec; 142(25):2146-2158. PubMed ID: 37738626
[TBL] [Abstract][Full Text] [Related]
60. Altered platelet-megakaryocyte endocytosis and trafficking of albumin and fibrinogen in RUNX1 haplodeficiency.
Del Carpio-Cano F; Mao G; Goldfinger LE; Wurtzel J; Guan L; Alam MA; Lee K; Poncz M; Rao AK
Blood Adv; 2024 Apr; 8(7):1699-1714. PubMed ID: 38330198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
